The use of cannabidiol (CBD) products for pets, particularly dogs, has gained considerable popularity in recent years, driven by anecdotal reports of its benefits for conditions such as pain, anxiety, and seizures. However, veterinarians and researchers caution that scientific evidence supporting these uses remains limited and inconclusive.

CBD is a compound derived from the hemp plant that does not produce the psychoactive effects associated with tetrahydrocannabinol (THC), the primary intoxicating agent in cannabis. It is widely marketed in various human formulations including oils, pills, and edibles. In the pet market, CBD products such as treats and oils have become increasingly available, with some dog owners using them to address ailments ranging from arthritis and dementia to seizures and hip dysplasia.

Veterinary experts emphasize that research on the efficacy and safety of CBD for animals is still in the early stages. Studies conducted so far have often involved small sample sizes and short durations, and some have been funded by the CBD industry, raising questions about the breadth and impartiality of data. For example, research on dogs with epilepsy has shown mixed results, with some evidence indicating a reduction in the number of seizure days among dogs receiving CBD compared to those given a placebo, but no significant overall decrease in seizure frequency.

Investigations into CBD for chronic pain, particularly related to osteoarthritis, have also produced variable outcomes. A small study found that most dogs receiving CBD oil reported lower pain levels, although many were concurrently treated with other pain medications such as gabapentin. Conversely, other trials found no significant difference between CBD and placebo treatments. Similarly, limited data suggest CBD may ease itching in dogs with atopic dermatitis when used alongside conventional therapies. However, claims that CBD reduces anxiety or aggressive behavior in dogs have not been strongly supported by scientific studies.

Safety concerns remain paramount. While CBD is generally considered safe for most healthy dogs, long-term effects are largely unknown. Some research has linked CBD use to elevated liver enzymes, which could indicate liver stress or damage. Possible side effects reported include nausea, vomiting, drooling, decreased appetite, and wobbliness. In addition, because CBD pet products are not regulated or approved by the U.S. Food and Drug Administration (FDA), there is a risk of inaccurate labeling, contamination, or the presence of higher-than-allowed THC levels, which can be harmful to dogs.

Veterinarians urge pet owners to consult with them before administering CBD to their animals, especially given the potential for interactions between CBD and other medications, such as anti-seizure drugs or nonsteroidal anti-inflammatory drugs. Experts also recommend purchasing products that provide third-party certification detailing cannabinoid content and verifying the absence of harmful substances.

Although public interest in CBD for pets continues to grow, veterinary professionals caution that it should not be considered a cure-all. Established treatments for many pet health conditions remain more thoroughly studied and reliable. Ongoing research and regulatory scrutiny by agencies such as the FDA aim to better understand the role and safety of CBD in veterinary medicine.